Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Toregem BioPharma develops regenerative dental therapies that promote growth of tooth buds (tooth germs) by using neutralizing anti-USAG-1 antibodies, a negative regulator of tooth development. The company aims to restore missing teeth in patients with congenital tooth loss and to regenerate the tertiary dental lamina to improve oral function in elderly patients. Toregem targets regenerative dentistry and oral healthcare markets by advancing biologic therapeutics to extend healthy lifespans through restoration of dental structures.